Geneoscopy Overview
- Founded
-
2015

- Status
-
Private
- Employees
-
54

- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$105M
- Investors
-
17
Geneoscopy General Information
Description
Developer of a diagnostics technology designed to treat digestive diseases and also offer cancer screening services. The company's technology consistently extracts stool-derived eukaryotic RNA (seRNA) transcripts and detects changes in gene expression, enabling doctors to better prevent, detect and guide treatment for gastrointestinal disease.
Contact Information
Website
www.geneoscopy.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
- 2220 Welsch Industrial Court
- Saint Louis, MO 63146
- United States
Geneoscopy Timeline
Geneoscopy Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Later Stage VC (Series B) | 16-Nov-2021 | $105M | 00000 | 00000 | Completed | Generating Revenue |
8. Later Stage VC | 01-Jan-2021 | 00.000 | Completed | Generating Revenue | ||
7. Debt - PPP | 08-Apr-2020 | 00.000 | Completed | Generating Revenue | ||
6. Early Stage VC (Series A) | 18-Sep-2019 | 00.000 | 00.000 | 000.00 | Completed | Generating Revenue |
5. Grant | 15-Nov-2016 | 0000 | 00000 | Completed | Startup | |
4. Grant | 01-Jan-2016 | 0000 | 00000 | Completed | Startup | |
3. Accelerator/Incubator | 00000 | 00000 | Completed | Startup | ||
2. Accelerator/Incubator | $22.6K | Completed | Startup | |||
1. Capitalization | 01-Jan-2015 | $22.6K | $22.6K | Completed | Startup |
Geneoscopy Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B-1 | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
Series B | 0,000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
Series A-1 | 239,352 | $0.000100 | $4.27 | $4.27 | 1x | $4.27 | 6.3% | |
Series A | 973,898 | $0.000100 | $7.4 | $7.4 | 1x | $7.4 | 25.64% |
Geneoscopy Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of a diagnostics technology designed to treat digestive diseases and also offer cancer screening services. The
Diagnostic Equipment
Saint Louis, MO
54
As of 2022
00000
0000
0000-00-00
00000000000
00000
Geneoscopy Competitors (20)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Clinical Genomics | Venture Capital-Backed | Bridgewater, NJ | 00 | 0000 | 00000000000 | 0000 |
0000000 0000000000 | Venture Capital-Backed | Beverly, MA | 00 | 00.00 | 0000000000 0 | 00.00 |
0000000 | Venture Capital-Backed | Irvine, CA | 000 | 00000 | 00000000 | |
00000 00000000 | Formerly VC-backed | Madison, WI | 0000 | 00.000 | 00000000 | 00.000 |
0000000000 0000000 | Formerly VC-backed | Cambridge, MA | 0000 | 00000 | 00000000000 |
Geneoscopy Patents
Geneoscopy Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2019276577-A1 | Detection method | Pending | 01-Jun-2018 | 0000000000 | |
CA-3136405-A1 | Detection method | Pending | 01-Jun-2018 | 0000000000 | |
EP-3802885-A4 | Detection method | Pending | 01-Jun-2018 | 0000000000 | |
EP-3802885-A1 | Detection method | Pending | 01-Jun-2018 | 0000000000 | |
US-20210214797-A1 | Detection method | Pending | 01-Jun-2018 | C12Q1/6886 |
Geneoscopy Executive Team (8)
Geneoscopy Board Members (6)
Name | Representing | Role | Since |
---|---|---|---|
Andrew Barnell | Geneoscopy | Co-Founder, Chief Executive Officer, Chief Finance Officer & Board Member | 000 0000 |
Bobby Sandage Ph.D | Cultivation Capital | Board Member | 000 0000 |
Drew Dennison | Self | Board Member | 000 0000 |
James Merselis | Self | Board Member | 000 0000 |
Mark Zorensky | Self | Board Member | 000 0000 |
Geneoscopy Signals
Geneoscopy Investors (17)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
BioGenerator | Venture Capital | Minority | 000 0000 | 000000 0 | |
Innovatus Capital Partners | Asset Manager | Minority | 000 0000 | 000000 0 | |
LabCorp Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
Morningside Group | Venture Capital | Minority | 000 0000 | 000000 0 | |
iSelect Fund | Venture Capital | Minority | 000 0000 | 000000 0 |